89bio (NASDAQ: ETNB)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of 89bio (NASDAQ: ETNB) through any online brokerage.
The latest price target for 89bio (NASDAQ: ETNB) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ETNB to fall to within 12 months (a possible -8.05% downside). 50 analyst firms have reported ratings in the last year.
The stock price for 89bio (NASDAQ: ETNB) is $4.35 last updated August 12, 2022, 8:00 PM UTC.
The next 89bio (ETNB) dividend date is projected to be Thursday, September 1, 2022.
89bio’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for 89bio.
89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.